Serum sickness questions are classic “looks like allergy, behaves like immune complex disease” traps. The fastest way to boost your Q-bank scores is to stop hunting only for the correct answer and start eliminating distractors by mechanism. Let’s run a serum sickness vignette the way test writers think—then break down why every answer choice matters.
Tag: Immunology > Hypersensitivity Reactions
The Vignette (Typical Q-bank Style)
A 24-year-old woman is treated with amoxicillin-clavulanate for sinusitis. Nine days later she develops fever, diffuse urticarial rash, and polyarthralgias. Exam shows generalized lymphadenopathy and mild edema of the hands. Labs reveal low C3 and C4. Urinalysis shows mild proteinuria.
Which mechanism best explains her symptoms?
The Correct Answer: Type III Hypersensitivity (Immune Complex–Mediated)
Why serum sickness is Type III
Serum sickness occurs when circulating antigen (often a drug or foreign protein) forms immune complexes with antibodies (usually IgG, sometimes IgM). These complexes deposit in tissues—especially:
- Blood vessels (vasculitis)
- Joints (arthralgias/arthritis)
- Kidneys (glomerulonephritis)
Mechanism (Step 1 + Step 2 relevant)
- Antigen exposure (e.g., cefaclor, penicillins, sulfonamides; biologics; antivenom; antithymocyte globulin)
- Antibody formation over days → immune complexes form in circulation
- Deposition in tissues → complement activation
- C3a/C5a recruit neutrophils → inflammation + tissue damage
- Complement consumption → low C3/C4
The high-yield clinical triad
Think: Fever + urticarial rash + arthralgias (often with lymphadenopathy)
Timing clue
- Typically 1–2 weeks after exposure (can be faster with re-exposure)
Lab clue
- Low complement (C3/C4) is a big neon sign for immune complex disease (also seen in SLE flares, post-strep GN, cryoglobulinemia)
Serum Sickness vs Serum Sickness–Like Reaction (Easy to Confuse)
| Feature | Serum sickness (true Type III) | Serum sickness–like reaction |
|---|---|---|
| Trigger | Foreign proteins (antivenom, ATG), some biologics; can be drugs | Often cefaclor, amoxicillin, others |
| Immune complexes | Yes | Not consistently demonstrated |
| Complement levels | Low C3/C4 | Often normal |
| Classic symptoms | Fever, urticaria, arthralgias, ± GN | Similar symptoms; renal disease less typical |
| Timing | ~7–14 days | ~5–10 days |
Test strategy: If the stem hands you low complement, they’re pushing you toward true Type III.
Why the Distractors Are Wrong (and When They’d Be Right)
Below are common answer choices that show up in hypersensitivity questions—and the exact detail you should look for to eliminate them.
Distractor A: Type I Hypersensitivity (IgE-Mediated Mast Cell Degranulation)
What it is: Immediate allergy/anaphylaxis due to IgE cross-linking on mast cells → histamine, tryptase, leukotrienes.
Why it’s wrong here:
- Serum sickness is delayed (days to weeks), not minutes to hours
- Low complement is not a hallmark of Type I
When Type I would be right:
- Minutes after exposure: urticaria, wheeze, hypotension
- Examples: anaphylaxis to penicillin, peanut allergy, allergic rhinitis, asthma exacerbation
Key phrase to recognize: “Immediate,” “wheezing/bronchospasm,” “angioedema,” “hypotension.”
Distractor B: Type II Hypersensitivity (Antibody-Mediated Cytotoxicity)
What it is: IgG/IgM binds cell surface or ECM antigens → complement, opsonization, ADCC.
Why it’s wrong here:
- Serum sickness involves soluble antigen + immune complex deposition, not antibodies targeting a fixed cell surface antigen
- Low complement can occur in Type II, but the clinical picture would be more cell-specific (hemolysis, thrombocytopenia), not systemic immune complex symptoms.
When Type II would be right:
- Hemolytic anemia (e.g., penicillin-induced hemolysis)
- ITP, Goodpasture (linear deposition), pemphigus vulgaris, Graves, myasthenia gravis
Key phrase to recognize: “Direct Coombs positive,” “linear IF,” or a single targeted organ/cell line.
Distractor C: Type IV Hypersensitivity (T-cell Mediated, Delayed-Type)
What it is: T cells (Th1/Th17 or CD8+) drive inflammation and tissue injury.
Why it’s wrong here:
- Timing can be delayed (similar trap), but Type IV is cell-mediated—you don’t expect low complement
- Type IV typically produces contact dermatitis patterns or granulomatous inflammation, not immune complex features.
When Type IV would be right:
- Poison ivy (urushiol), nickel allergy
- PPD test reaction
- Granulomas: TB, sarcoidosis
- Severe drug reactions like DRESS (complex, often eosinophilia) and SJS/TEN (cytotoxic T cells; mucosal erosions)
Key phrase to recognize: “48–72 hours after exposure,” “vesicular rash in area of contact,” “granulomas,” “mucosal involvement” (SJS/TEN).
Distractor D: Immune Complex Deposition in the Basement Membrane with Linear Immunofluorescence
(Usually pointing to Goodpasture or anti-GBM disease)
Why it’s wrong here:
- Serum sickness has granular immune complex deposition (lumpy-bumpy), not linear
- The stem features systemic symptoms (fever, urticaria, arthralgia), not the pulmonary-renal syndrome classic for anti-GBM
When it would be right:
- Hemoptysis + hematuria
- Linear IgG along GBM on IF
Key phrase: “Pulmonary-renal syndrome,” “linear fluorescence.”
Distractor E: Immune Complex Deposition in Tissues Causing Complement Consumption
(This is essentially the correct answer, but may be phrased differently)
How to confirm you’re not overthinking:
- Timing: 1–2 weeks after exposure
- Symptoms: fever + rash (often urticarial) + arthralgia
- Labs: low C3/C4
High-Yield Associations (USMLE Favorites)
Common triggers to remember
- Foreign proteins: antivenom, antithymocyte globulin (ATG)
- Drugs: penicillins, cephalosporins (esp. cefaclor), sulfonamides
- Biologics/monoclonals: can cause immune complex–type reactions (test stems vary)
“Type III” diseases list you should have on autopilot
- Serum sickness
- SLE
- Post-streptococcal glomerulonephritis
- Polyarteritis nodosa (HBV-associated immune complexes)
- Hypersensitivity pneumonitis (farmer’s lung)
- Mixed cryoglobulinemia (often HCV)
Granular vs linear: the 5-second immunofluorescence rule
- Granular (“lumpy-bumpy”) = immune complexes (Type III)
- Linear = anti-GBM (Type II)
Management (What Step 2 Might Ask)
Most cases are self-limited once the offending agent is stopped.
- Stop the trigger
- Supportive care: antihistamines, NSAIDs for arthralgia
- Corticosteroids for more significant symptoms (e.g., severe arthritis, nephritis)
- Monitor renal involvement if UA is abnormal
Q-bank Takeaways: How to Nail It Fast
Use this quick elimination checklist:
- Delayed onset (7–14 days) after drug/foreign protein? → think Type III
- Low C3/C4? → immune complex disease until proven otherwise
- Fever + urticaria + arthralgia? → serum sickness pattern
- Linear IF? → Type II anti-GBM, not serum sickness
- Immediate wheeze/hypotension? → Type I, not serum sickness